Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Bodkin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurologic Clinics|November 23, 2020
Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic SyndromeCynthia Bodkin, Robert M Pascuzzi
Chest|December 3, 2014
A 44-year-old woman with excessive sleepiness. Opioid-induced central sleep apneaMaría Paula Tovar-Torres, Cynthia Bodkin, Ninotchka L Sigua
Annals of the American Thoracic Society|February 2, 2019
An Aliasing Polysomnographic FindingAnita Rajagopal, Ninotchka L Sigua, Cynthia Bodkin, et al.
Seminars in Neurology|November 23, 2022
Challenging Neuromuscular Disease CasesCynthia Bodkin, Adam Comer, Marcia Felker, et al.
JACC. Case Reports|February 20, 2026
Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C MutationsAlejandra Cardona Perez, Renee Moenning, Cynthia Bodkin, et al.
Plos Medicine|October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trialSteven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.
Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.
Muscle & Nerve|April 16, 2022
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophyJeffrey M Statland, Craig Campbell, Urvi Desai, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurologic Clinics|November 23, 2020
Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic SyndromeCynthia Bodkin, Robert M Pascuzzi
Chest|December 3, 2014
A 44-year-old woman with excessive sleepiness. Opioid-induced central sleep apneaMaría Paula Tovar-Torres, Cynthia Bodkin, Ninotchka L Sigua
Annals of the American Thoracic Society|February 2, 2019
An Aliasing Polysomnographic FindingAnita Rajagopal, Ninotchka L Sigua, Cynthia Bodkin, et al.
Seminars in Neurology|November 23, 2022
Challenging Neuromuscular Disease CasesCynthia Bodkin, Adam Comer, Marcia Felker, et al.
JACC. Case Reports|February 20, 2026
Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C MutationsAlejandra Cardona Perez, Renee Moenning, Cynthia Bodkin, et al.
Plos Medicine|October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trialSteven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.
Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.
Muscle & Nerve|April 16, 2022
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophyJeffrey M Statland, Craig Campbell, Urvi Desai, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Pageof 1